Ingrid Espinoza

1.3k total citations
28 papers, 1.0k citations indexed

About

Ingrid Espinoza is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ingrid Espinoza has authored 28 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Ingrid Espinoza's work include Cancer, Lipids, and Metabolism (7 papers), Peroxisome Proliferator-Activated Receptors (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Ingrid Espinoza is often cited by papers focused on Cancer, Lipids, and Metabolism (7 papers), Peroxisome Proliferator-Activated Receptors (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Ingrid Espinoza collaborates with scholars based in United States, Spain and Argentina. Ingrid Espinoza's co-authors include Lucio Miele, Fei Xing, Ruth Lupu, Javier A. Menéndez, Elisabet Cuyàs, Christian R. Gómez, Sara Verdura, Kristine Y. DeLeon‐Pennell, Barbara Schroeder and Ervin R. Fox and has published in prestigious journals such as SHILAP Revista de lepidopterología, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Ingrid Espinoza

28 papers receiving 1.0k citations

Peers

Ingrid Espinoza
Donna P. Frazier United States
Amanda Gunn United States
Rebecca E. McIntyre United Kingdom
Zarir E. Karanjawala United States
Marieke van de Ven Netherlands
Ingrid Espinoza
Citations per year, relative to Ingrid Espinoza Ingrid Espinoza (= 1×) peers Ezequiel Lacunza

Countries citing papers authored by Ingrid Espinoza

Since Specialization
Citations

This map shows the geographic impact of Ingrid Espinoza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingrid Espinoza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingrid Espinoza more than expected).

Fields of papers citing papers by Ingrid Espinoza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingrid Espinoza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingrid Espinoza. The network helps show where Ingrid Espinoza may publish in the future.

Co-authorship network of co-authors of Ingrid Espinoza

This figure shows the co-authorship network connecting the top 25 collaborators of Ingrid Espinoza. A scholar is included among the top collaborators of Ingrid Espinoza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingrid Espinoza. Ingrid Espinoza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Espinoza, Ingrid, et al.. (2023). Propiedades psicométricas del Cuestionario de Agresión (AQ) en estudiantes universitarios ecuatorianos. 9(18). 9–27. 1 indexed citations
2.
Gómez, Christian R., et al.. (2022). Correlation of cholesteryl ester metabolism to pathogenesis, progression and disparities in colorectal Cancer. Lipids in Health and Disease. 21(1). 22–22. 17 indexed citations
3.
Schroeder, Barbara, Ingrid Espinoza, Zeng Hu, et al.. (2021). Fatty acid synthase (FASN) regulates the mitochondrial priming of cancer cells. Cell Death and Disease. 12(11). 977–977. 62 indexed citations
4.
Menéndez, Javier A., Adriana Papadimitropoulou, Elisabet Cuyàs, et al.. (2021). Fatty Acid Synthase Confers Tamoxifen Resistance to ER+/HER2+ Breast Cancer. Cancers. 13(5). 1132–1132. 33 indexed citations
5.
Menéndez, Javier A., Inderjit Mehmi, Adriana Papadimitropoulou, et al.. (2020). Fatty Acid Synthase Is a Key Enabler for Endocrine Resistance in Heregulin-Overexpressing Luminal B-Like Breast Cancer. International Journal of Molecular Sciences. 21(20). 7661–7661. 23 indexed citations
6.
Papadimitropoulou, Adriana, Luciano Vellón, Ella Atlas, et al.. (2020). Heregulin Drives Endocrine Resistance by Altering IL-8 Expression in ER-Positive Breast Cancer. International Journal of Molecular Sciences. 21(20). 7737–7737. 10 indexed citations
7.
DeLeon‐Pennell, Kristine Y., Yonggang Ma, Rugmani Padmanabhan Iyer, et al.. (2019). Glycoproteomic Profiling Provides Candidate Myocardial Infarction Predictors of Later Progression to Heart Failure. ACS Omega. 4(1). 1272–1280. 11 indexed citations
8.
Espinoza, Ingrid, et al.. (2018). Genetic Mutations in B-Acute Lymphoblastic Leukemia Among African American and European American Children. Clinical Lymphoma Myeloma & Leukemia. 18(12). e501–e508. 4 indexed citations
9.
DeLeon‐Pennell, Kristine Y., Alan J. Mouton, Yonggang Ma, et al.. (2018). LXR/RXR signaling and neutrophil phenotype following myocardial infarction classify sex differences in remodeling. Basic Research in Cardiology. 113(5). 40–40. 88 indexed citations
10.
Sakiyama, Marcelo J., et al.. (2018). Abstract 66: MHC class I polypeptide related sequence A as contributing factor to chemotherapy-induced resistance. Cancer Research. 78(13_Supplement). 66–66. 1 indexed citations
11.
Espinoza, Ingrid, Marcelo J. Sakiyama, Tangeng Ma, et al.. (2016). Hypoxia on the Expression of Hepatoma Upregulated Protein in Prostate Cancer Cells. Frontiers in Oncology. 6. 144–144. 11 indexed citations
12.
Menéndez, Javier A., Barbara Schroeder, Luciano Vellón, et al.. (2015). Blockade of a Key Region in the Extracellular Domain Inhibits HER2 Dimerization and Signaling. JNCI Journal of the National Cancer Institute. 107(6). djv090–djv090. 11 indexed citations
13.
Miele, Lucio, et al.. (2013). Notch signaling: targeting cancer stem cells and epithelial-to-mesenchymal transition. OncoTargets and Therapy. 6. 1249–1249. 147 indexed citations
14.
Espinoza, Ingrid & Lucio Miele. (2013). Notch inhibitors for cancer treatment. Pharmacology & Therapeutics. 139(2). 95–110. 230 indexed citations
15.
Lupu‐Meiri, Monica, et al.. (2008). Plasminogen‐induced aggregation of PANC‐1 cells requires conversion to plasmin and is inhibited by endogenous plasminogen activator inhibitor‐1. Journal of Cellular Physiology. 216(3). 632–639. 8 indexed citations
16.
Li, Binghui, et al.. (2007). Inhibition of fatty acid synthase induces reactive oxygen species (ROS) to inhibit HER2 overexpressing breast cancer cell growth. Cancer Research. 67. 4462–4462. 1 indexed citations
17.
Galindo, Mario, Ingrid Espinoza, José Grenet, et al.. (2007). Chromosomal size conservation through the cell cycle supports karyotype stability in Trypanosoma cruzi. FEBS Letters. 581(10). 2022–2026. 5 indexed citations
18.
Espinoza, Ingrid, Christian R. Gómez, Mario Galindo, & Norbel Galanti. (2006). Developmental expression pattern of histone H4 gene associated to DNA synthesis in the endoparasitic platyhelminth Mesocestoides corti. Gene. 386(1-2). 35–41. 8 indexed citations
19.
Galindo, Mario, Nelson Varela, Ingrid Espinoza, et al.. (2004). Chromatin from two classes of platyhelminthes display both protist H1 and higher eukaryote core histones. FEBS Letters. 567(2-3). 225–229. 5 indexed citations
20.
Markoski, Melissa Medeiros, Cristiano Valim Bizarro, Sandra Estrazulas Farias, et al.. (2003). IN VITRO SEGMENTATION INDUCTION OF MESOCESTOIDES CORTI (CESTODA) TETRATHYRIDIA. Journal of Parasitology. 89(1). 27–34. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026